Aim & Scope

The Journal of Cancer and Translational Oncology (JCTO) is dedicated to advancing scientific knowledge and clinical innovation in oncology, cancer biology, and translational medicine. The primary aim of the journal is to provide an international platform for researchers, clinicians, and healthcare professionals to publish impactful research that bridges fundamental cancer biology with clinical applications.

The journal seeks to promote research that enhances the understanding of cancer initiation, progression, diagnosis, treatment, and prevention. It emphasizes translational studies that convert laboratory discoveries into practical medical solutions that improve patient care and survival outcomes.

The scope of the journal includes a wide range of topics in cancer research and related biomedical sciences, including but not limited to:

  • Molecular and Cellular Oncology

  • Cancer Genetics and Genomics

  • Cancer Epigenetics and Gene Regulation

  • Tumor Immunology and Cancer Immunotherapy

  • Targeted Therapy and Precision Oncology

  • Cancer Biomarkers and Diagnostic Tools

  • Clinical Oncology and Clinical Trials

  • Radiation Oncology and Chemotherapy

  • Cancer Pharmacology and Drug Resistance

  • Tumor Microenvironment and Metastasis

  • Cancer Prevention and Early Detection Strategies

  • Translational Cancer Research

  • Bioinformatics and Computational Oncology

  • Artificial Intelligence in Cancer Diagnosis and Treatment

  • Nanomedicine and Drug Delivery Systems

  • Pediatric and Geriatric Oncology

  • Hematological Malignancies

  • Surgical Oncology and Emerging Treatment Techniques

The journal strongly encourages interdisciplinary research that integrates oncology with molecular biology, immunology, genetics, pharmacology, biotechnology, data science, and medical engineering.

By providing open access to all published content, the journal ensures rapid and unrestricted dissemination of scientific knowledge, enabling global collaboration and accelerating advancements in cancer research and treatment strategies.

Through its commitment to scientific excellence, ethical publishing practices, and translational innovation, the Journal of Cancer and Translational Oncology aims to contribute significantly to improving cancer diagnosis, therapy, and patient outcomes worldwide.